Long-term administration of calcitonin for hypercalcemia secondary to recurrent parathyroid carcinoma.
D002116:Calcitonin / Q000008:administration & dosage*; D002118:Calcium / Q000097:blood; D002277:Carcinoma / Q000150:complications*; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy*; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008274:Magnesium / Q000097:blood; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000150:complications; D010282:Parathyroid Neoplasms / Q000150:complications*; D010758:Phosphorus / Q000097:blood; D011188:Potassium / Q000097:blood; D012964:Sodium / Q000097:blood
D010758:Phosphorus; D002116:Calcitonin; D012964:Sodium; D008274:Magnesium; D011188:Potassium; D002118:Calcium